Patient Demographics
| Variable | Evaluable baseline PET scan (n = 17) | Evaluable for response to treatment (n = 12) |
| Age (years) | ||
| Median | 70 | 75 |
| Range | 48–86 | 58–86 |
| Primary Gleason score | ||
| Mean | 4 | 4 |
| SD | 0.8 | 0.8 |
| PSA (ng/mL) | ||
| Mean | 433 | 235 |
| SD | 1,012 | 368 |
| Initial treatment | ||
| Dasatinib | 13 | 10 |
| Nilutamide | 4 | 2 |
| Eastern Cooperative Oncology Group performance status | ||
| 0 | 12 | 9 |
| 1 | 5 | 3 |
| uNTX (nM/mmol Cr) | ||
| Mean | 76 | 61 |
| SD | 104 | 76 |
| BAP (U/L) | ||
| Mean | 60 | 20 |
| SD | 130 | 15 |